|
|
H-Guard (China) Co., Ltd., a national “High And New Technology Enterprise” certificated company, was founded by ambitious scientists of returnees and entrepreneurs in August 2013, based in Shenzhen, a modern high-tech city in China. Now we have more than 80 employees, over 90% of them have bachelor a degree or above.
H-Guard (China) Co., Ltd. is a bio-medical company specializing in IVD (In Vitro Diagnostic) Reagents, Clinical Laboratory Instruments, and we also own core key technology in raw material development such as monoclonal antibodies and recombinant proteins for IVD industry. Currently, the company focuses on four categories of IVD detection platform: Colloidal Gold, Quantum Dot Immunofluorescence, Latex Enhanced Immunoturbidimetry, ELISA. All these platforms cover the detection for Cardiovascular Disease, Inflammation Monitoring, Glyco Metabolism, Tumor Markers, or Infectious Disease, etc.
H-Guard (China) has a number of world-leading technological bio-medical and IVD projects, of which the most competitive ones are MPO (myeloperoxidase) and Lp-PLA2 (Lipoprotein-associated phospholipase A2) for detecting, altering and evaluating the early risk of stroke and heart attack.
With the outstanding team on R&D, Production, and Sale, our market share is thriving, we devote ourselves to building the first diagnosis brand which is worthy of trust!
